135 karma · joined June 9, 2018
It's not only about vaccines but about treatments in general. There is a good chance that we'll have a drug that significantly improves outcomes long before we have a vaccine. I don't understand how a peer-reviewed paper can overlook this.
The evidence is overwhelming. Questioning it is an extraordinary claim. Extraordinary claims require extraordinary evidence.
I won't comment further.
You seem to be misinterpreting the statement, which says that even though "only" 30% of additional deaths are proven to be caused by the virus, the real number is likely higher.
It should be obvious that the situation in northern Italy is far beyond "reasonable variance". Google is your friend.
0%. Just read the reports from Wuhan and Italy. For example, citing from https://www.worldometers.info/coronavirus/country/italy/:
March 20 (GMT)
Italy: in the city of Bergamo, there were 108 more deaths in the first 15 days of March this year compared to 2019 (164 deaths in 2020 vs. 56 deaths in 2019) according to the mayor of the city Giorgio Gori. During this period, 31 deaths were attributed to the coronavirus (less than 30% of the additional deaths this year)
"There are significant numbers of people who have died but whose death hasn't been attributed to the coronavirus because they died at home or in a nursing home and so they weren't swabbed," said the mayor [source]
March 19 (GMT)
Italian army trucks form a long line in the center of Bergamo to transport the coffins from the Bergamo cemetery to cremation sites in other regions, as morgues can't cope with more coronavirus deaths
Obituaries in the local newspaper went from 1.5 pages (on Feb. 9) to 10 pages (on March 13)
* Santa Clara County has over double the population of SF County.
* Santa Clara County has always been ahead of SF County in confirmed cases.
* According to https://projects.sfchronicle.com/2020/coronavirus-map/, the ratio has stayed roughly the same over the last two weeks (3:1).
* Interestingly, LA County had fewer confirmed cases than SF County until 11 days ago.
Who said it will solve it? It will flatten the curve as it already has in other countries, hopefully avoiding a catastrophic overload of the healthcare system.
GraalVM CE is licensed under GPL 2 with Classpath exception (https://github.com/oracle/graal/blob/master/LICENSE), specifically so that binaries created with GraalVM (which contain the GraalVM runtime) don't fall under the GPL.
> Can you source that claim?
From https://www.azul.com/eliminating-java-update-confusion/:
Oracle stated that their goal was to eliminate any functional differences between these two binaries. This will be complete with the release of JDK 11 in September. To achieve this goal, certain features (such as Flight Recorder and Mission Control) have been contributed to the OpenJDK project, whilst other features (like Java Web Start and JavaFX) are being removed from the Oracle JDK.
From http://www.oracle.com/technetwork/java/javase/eol-135779.htm...:
As announced in September 2017, with the OracleJDK and builds of Oracle OpenJDK being interchangeable for releases of Java SE 11 and later, [...]
You will have to pay for using Oracle JDK 11 and higher in prod, which is built from the exact same codebase as OpenJDK 11 but offers commercial support and long-term support (LTS) releases.
https://adoptopenjdk.net plans to ship LTS releases of OpenJDK for free.
https://mjg123.github.io/2018/05/25/Opening-Oracle-JDK-Featu...
Use of GPL licensed software is heavily restricted in many corporations, whether or not it has the Classpath Exception. Among other things, it's hard to verify/enforce that projects only link against files that have the Classpath Exception.
You have to pay for Oracle JDK but not for OpenJDK, which is just as good, except for a less business-friendly license, no commercial support, and no LTS builds straight from Oracle (instead you need to put your bets on adoptopenjdk.net).
> Quoting the article: «Oracle JDKs may only be used in production if you buy the commercial support.»
Yes, but the author forgets about this in the "What does the new release train mean to my company?" section and draws completely wrong conclusions.
> The alternative is using OpenJDK in production. We'll have to see how much the Oracle JDK and OpenJDK will diverge.
They will be identical. All of Oracle's JDK work, even LTS related work, will go into the OpenJDK repo.